Middle East Healthcare Company (TADAWUL:4009)
33.38
-0.08 (-0.24%)
Sep 3, 2026, 3:15 PM AST
TADAWUL:4009 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | - | 3,103 | 2,883 | 2,653 | 2,152 | 1,873 |
Revenue Growth | - | 7.63% | 8.66% | 23.30% | 14.90% | 6.97% |
Gross Profit Gross Profit Growth | - | 1,146 | 1,102 | 1,004 | 671.99 | 595.14 |
Operating Income Operating Income Growth | - | 387.3 | 440.93 | 323.97 | 140.34 | 54.24 |
Net Income Net Income Growth | - | 301.88 | 282 | 17.04 | 75.18 | 17.2 |
Earnings Per Share EPS Growth | - | 3.28 | 3.06 | 0.19 | 0.82 | 0.19 |
EPS Growth | - | 7.05% | 1555.10% | -77.34% | 337.08% | -79.02% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
In Patient Services In Patient Services Growth | 1,785 | 1,723 | 1,628 | 1,545 | 1,239 | 1,098 |
Outpatient Services Outpatient Services Growth | 987.48 | 968.93 | 852.68 | 740.19 | 587.88 | 491.24 |
Others Others Growth | 12.13 | 3.28 | 8.77 | 6.59 | 11.34 | 17.66 |
Pharmacy Sales Pharmacy Sales Growth | 404.21 | 407.75 | 393.25 | 361.06 | 313.54 | 265.42 |
Total Total Growth | 3,189 | 3,103 | 2,883 | 2,653 | 2,152 | 1,873 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 82.54 | 26.3 | 52.28 | 44.42 | 15.6 | 28.13 |
Total Debt Total Debt Growth | 2,482 | 2,544 | 2,466 | 2,485 | 2,240 | 1,967 |
Net Cash (Debt) Net Cash Growth | -2,399 | -2,517 | -2,414 | -2,441 | -2,225 | -1,939 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | - | -27.35 | -26.22 | -26.52 | -24.17 | -21.06 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 544.6 | 766 | 191.08 | 76.02 | 76.62 |
Capital Expenditures CapEx Growth | - | -455.16 | -470.82 | -229.61 | -249.52 | -416.56 |
Free Cash Flow Free Cash Flow Growth | - | 89.44 | 295.18 | -38.53 | -173.5 | -339.94 |
Free Cash Flow Growth | - | -69.70% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | 36.94% | 38.23% | 37.83% | 31.23% | 31.78% |
Operating Margin | - | 12.48% | 15.29% | 12.21% | 6.52% | 2.90% |
Pretax Margin | - | 10.49% | 10.76% | 7.20% | 3.77% | 1.03% |
Profit Margin | - | 9.73% | 9.78% | 0.64% | 3.49% | 0.92% |
FCF Margin | - | 2.88% | 10.24% | -1.45% | -8.06% | -18.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | - |
Dividend Yield | 1.49% | 1.56% | 0.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 9.93 | 22.42 | 476.99 | 31.16 | 169.35 |
Forward PE | 17.83 | 10.52 | 22.96 | 32.62 | 24.51 | 27.34 |
P/FCF Ratio | - | 33.51 | 21.42 | - | - | - |
PS Ratio | - | 0.97 | 2.19 | 3.06 | 1.09 | 1.56 |